Rahko
![](https://www.aci-lifesciences.com/wp-content/uploads/2023/04/rahko-square.png)
Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine.
Ochre Bio
![](https://www.aci-lifesciences.com/wp-content/uploads/2023/04/Untitled-design.png)
Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally. Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub.